Diabetes domain

This indicator shows the number and percent of people with diabetes receiving any hypoglycaemic medication regularly. Regular use was defined as hypoglycaemic medication dispensed in three or more quarters in a year

This indicator shows the number and percent of people with diabetes receiving sulfonylureas (glibenclamide, gliclazide and glipizide) regularly. Regular use was defined as sulfonylureas dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving dulaglutide regularly. Regular use was defined as dulaglutide dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving empagliflozin regularly. Regular use was defined as empagliflozin dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving vildagliptin regularly. Regular use was defined as vildagliptin dispensed in three or more quarters in a year.

This indicator shows the number and percent of the PHO enrolled New Zealand population recorded as having diabetes in the VDR.

This indicator shows the number and percent of people with diabetes dispensed insulin regularly. Regular use was defined as insulin dispensed in three or more quarters in a year.

This indicator shows the number and percent of people with diabetes receiving metformin regularly. Regular use was defined as metformin dispensed in three or more quarters in a year. 

This indicator shows the number and percent of people with diabetes undergoing a lower-limb amputation.

This measure shows the percentage of people with diabetes admitted to hospital with diabetic ketoacidosis as the primary diagnosis.